Platelet Transfusion: Indications, Patient Groups, and Clinical Use
Platelet transfusions are indicated for thrombocytopenia or platelet dysfunction with bleeding risk.
Key Patient Groups
- Thrombocytopenia: Chemotherapy, marrow failure, DIC, sepsis, drug-induced (heparin, quinine). Transfuse if <10×10⁹/L (prophylactic) or <50×10⁹/L (active bleeding/surgery).
- Immune thrombocytopenia (ITP): Autoantibodies destroy platelets. Transfuse for severe bleeding; otherwise steroids/IVIG/TPO-RAs first.
- Hematologic malignancies (leukemia, lymphoma): Disease + chemo → thrombocytopenia. Frequent transfusions during induction.
- Massive hemorrhage: Trauma, surgery, PPH – part of massive transfusion protocol (1:1:1 RBC:plasma:platelets).
- Inherited platelet disorders: Glanzmann thrombasthenia, Bernard-Soulier, Wiskott-Aldrich – transfuse for bleeding/procedures.
- Post-transplant (HSCT/solid organ): Conditioning regimen causes thrombocytopenia; support until engraftment.
- Pediatrics: Neonatal alloimmune thrombocytopenia (NAIT), chemotherapy, congenital disorders.
Product
Apheresis (single donor) or pooled whole-blood derived; leukoreduced, irradiated if needed. ABO-compatible preferred.
Blood Disorders - Related Articles
- Blood Clot Formation: Platelets, Fibrin, and the Coagulation Cascade
- Viral Meningitis: Origins, Causes, and Symptoms - A Comprehensive Guide
- Hepatitis B: Symptoms, Diagnosis & Risk Factors for Men & Women
- Blood Components: Red Cells, White Cells, Platelets, and Their Functions
- Legal Consumption of Blood: A Global Overview
- Red Cross Blood Donation Safety: How Infections Are Prevented
- Red Blood Cell Swelling & Shrinkage: Osmotic Pressure Explained
